Manh-Cuong Vo

发表

Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2022, Translational oncology.

A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine

Young Seob Kim, H. Park, Yeong‐Min Park, 2019, Journal of Immunotherapy for Cancer.

Natural killer cells have a synergistic anti-tumor effect in combination with chemoradiotherapy against head and neck cancer.

Je-Jung Lee, M. Yoon, Sung-Hoon Jung, 2022, Cytotherapy.

Synergistic Antimyeloma Activity of Dendritic Cells and Pomalidomide in a Murine Myeloma Model

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2018, Front. Immunol..

Chaetocin enhances dendritic cell function via the induction of heat shock protein and cancer testis antigens in myeloma cells

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2017, Oncotarget.

Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21

Junsang Doh, Je-Jung Lee, Hyeoung-Joon Kim, 2021, Cancer Immunology, Immunotherapy.

Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Sung-Hoon Jung, 2019, Cancer Immunology, Immunotherapy.

Generation of multiple peptide cocktail-pulsed dendritic cells as a cancer vaccine.

Je-Jung Lee, Hyun-ju Lee, My-Dung Hoang, 2014, Methods in molecular biology.

Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2015, Journal of immunotherapy.

Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2022, Cancer Immunology, Immunotherapy.

Lenalidomide enhances the function of dendritic cells generated from patients with multiple myeloma.

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2017, Experimental hematology.

Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma

J. Rhee, Je-Jung Lee, Hyun-ju Lee, 2018, Front. Immunol..

Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model

Sung-Hoon Jung, Manh-Cuong Vo, Je-Jung Lee, 2017, Oncotarget.

Sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cells

Je-Jung Lee, Hyun-Ju Lee, Hyeoung-Joon Kim, 2016, Experimental & Molecular Medicine.

Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity

J. Rhee, S. Shin, Je-Jung Lee, 2015, Oncotarget.

Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2015, Chonnam medical journal.

Dendritic cells loaded with myeloma cells pretreated with a combination of JSI-124 and bortezomib generate potent myeloma-specific cytotoxic T lymphocytes in vitro.

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2014, Experimental hematology.

A novel function of API5 (apoptosis inhibitor 5), TLR4-dependent activation of antigen presenting cells

Young Seob Kim, T. Wu, H. Park, 2018, Oncoimmunology.

Cellular immunotherapy in multiple myeloma

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2019, The Korean journal of internal medicine.

Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2021, Cellular & Molecular Immunology.

Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve the Immunogenicity of Tumor Antigens and Enhance Th1 Polarization of Dendritic Cells

I. Park, Je-Jung Lee, Hyeoung-Joon Kim, 2015, Journal of immunology research.

Immunotherapy for the treatment of multiple myeloma.

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2017, Critical reviews in oncology/hematology.

Generation of potent dendritic cells with improved migration ability through p-cofilin and sarco/endoplasmic reticulum Ca(2+) transport ATPase 2 regulation.

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2015, Cytotherapy.

Lenalidomide Synergistically Enhances the Effect of Dendritic Cell Vaccination in a Model of Murine Multiple Myeloma

Je-Jung Lee, Hyun-ju Lee, Hyeoung-Joon Kim, 2015, Journal of immunotherapy.

Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment

Manh-Cuong Vo, Thanh Thien Le, S. Jung, 2023, Frontiers in oncology.

Exploring cellular immunotherapy platforms in multiple myeloma

Jae-Sook Ahn, Seo-Yeon Ahn, Mi-Hyun Kim, 2024, Heliyon.

A combination of immunoadjuvant nanocomplexes and dendritic cell vaccines in the presence of immune checkpoint blockade for effective cancer immunotherapy

Saji Uthaman, I. Park, Je-Jung Lee, 2021, Cellular & Molecular Immunology.